RXII $.98 ASCO Blockbuster results RXII could be $3 in no time like ZLCS and ACAD RXII has a blockbuster cancer vaccine with unprecedented results approved for an SPA. The vaccine reduced breast cancer recurrance from 14% to 2%. That trumps DNDN. Updated results at ASCO.